| Market cap | $99.18B |
|---|---|
| Enterprise value | $148.63B |
| Revenue | $7.319B |
|---|---|
| EBITDA | $2.287B |
| Income | $1.988B |
| Revenue Q/Q | 11.46% |
| Revenue Y/Y | 13.81% |
| P/E | 78.82 |
|---|---|
| Forward P/E | 69.67 |
| EV/Sales | 20.31 |
| EV/EBITDA | 64.99 |
| EV/EBIT | 72.17 |
| PEG | 3.40 |
| Price/Sales | 13.55 |
| P/FCF | 166.46 |
| Price/Book | 7.45 |
| Book/Share | 59.65 |
| Cash/Share | 23.41 |
| FCF yield | 0.60% |
| Volume | 1.075M / 1.167M |
|---|---|
| Relative vol. | 0.92 × |
| EPS | 5.64 |
|---|---|
| EPS Q/Q | 0.00% |
| Est. EPS Q/Q | -3.85% |
| Profit margin | 25.24% |
|---|---|
| Oper. margin | 25.26% |
| Gross margin | 66.39% |
| EBIT margin | 28.14% |
| EBITDA margin | 31.25% |
| Ret. on assets | 13.28% |
|---|---|
| Ret. on equity | 15.38% |
| ROIC | 13.73% |
| ROCE | 14.25% |
| Debt/Equity | 0.15 |
|---|---|
| Net debt/EBITDA | -9.75 |
| Current ratio | 5.55 |
| Quick ratio | 4.61 |
| Volatility | 1.83% |
|---|---|
| Beta | 1.39 |
| RSI | 66.66 |
|---|
| Insider ownership | 0.50% |
|---|---|
| Inst. ownership | 87.25% |
| Shares outst. | 354.700M |
|---|---|
| Shares float | 0.000 0.00% |
| Short % of float | 0.94% |
| Short ratio | 1.77 |
| Dividend | N/A |
|---|---|
| Dividend yield | N/A |
| Payout ratio | N/A |
| Payment date | N/A |
| Ex-dividend date | N/A |
| Earnings date | 18 Jul 2024 |
Monday, 24 June 2024
|
|
| Intuitive Surgical Inc. : Are Analysts Optimistic About This Healthcare Stock? | |
Saturday, 18 May 2024
|
|
| Microsoft Leads Five Stocks Near Buy Points As Market Flashes Green | |
Friday, 17 May 2024
|
|
| Intuitive Surgical, IBD Stock Of The Day, Feels Its Way Toward Buy Point | |
Tuesday, 14 May 2024
|
|
| Autonomous Operations Could Threaten Intuitive Surgical's Moat in Robotic Surgery | |
Tuesday, 7 May 2024
|
|
| 13 Best Stocks That Will Always Grow | |
Friday, 3 May 2024
|
|
| Intuitive Surgical Builds On Its Robotic Surgery Prowess. But Challengers Are Coming. | |
Saturday, 20 April 2024
|
|
| Decoding Intuitive Surgical Inc : A Strategic SWOT Insight | |
Thursday, 18 April 2024
|
|
| Intuitive Surgical Narrowly Beats First-Quarter Expectations, But Shares Remain Muted | |
Thursday, 28 March 2024
|
|
| 20 Best Stocks to Buy Right Now According to Financial Media | |
Thursday, 14 March 2024
|
|
| Intuitive Surgical Pops After Winning FDA Clearance For Next-Gen Robotic System | |
Saturday, 9 March 2024
|
|
| Wall Street Picked These 13 AI Stocks for 2024 | |
Wednesday, 6 March 2024
|
|
| 15 Countries with the Best Public Health Systems in the World | |
Monday, 19 February 2024
|
|
| 15 Best Large-Cap Stocks to Buy in 2024 | |
Sunday, 18 February 2024
|
|
| 15 Best Stocks For Long Term Growth | |
Saturday, 17 February 2024
|
|
| 12 Best Breakout Stocks To Buy Right Now | |
Tuesday, 13 February 2024
|
|
| Intuitive Surgical Inc EVP & Chief Medical Officer Myriam Curet Sells Company Shares | |
Monday, 29 January 2024
|
|
| Intuitive Surgical Inc EVP & Chief Medical Officer Myriam Curet Sells 4,318 Shares | |
| 15 Best Stocks To Buy According to Billionaires | |
Tuesday, 23 January 2024
|
|
| Robotic Surgery Behemoth Intuitive Surgical Beats Earnings Views, But Shares Yo-Yo | |
Monday, 22 January 2024
|
|
| 12 S&P 500 Stocks On the Move | |
Friday, 19 January 2024
|
|
| Intuitive Surgical, Inc. is Attracting Investor Attention: Here is What You Should Know | |
Thursday, 18 January 2024
|
|
| Intuitive Surgical Surges To A Record High With Rivals On The Horizon 'Unlikely To Derail' It | |
Wednesday, 17 January 2024
|
|
| Reasons to Retain Intuitive Surgical in Your Portfolio Now | |
Tuesday, 16 January 2024
|
|
| Intuitive Surgical, Inc. Suffers a Larger Drop Than the General Market: Key Insights | |
| Insider |
Trans.
Transaction
|
Total value |
|---|---|---|
| Craig H Barratt Director | Option 12 Jun 2024 | $79,758 |
| Robert De Santis EVP, Chief Strategy, and Corp Op | Option 10 Jun 2024 | $63,782 |
| David J. Rosa President | Option 10 Jun 2024 | $568,578 |
| Craig H Barratt Director | Option 5 Jun 2024 | $79,758 |
| Craig H Barratt Director | Option 3 Jun 2024 | $142,197 |
| Robert De Santis EVP, Chief Strategy, and Corp Op | Option 28 May 2024 | $211,273 |
| Mark Brosius SVP, Chief Mfg, and Supply Cha | Sale 16 May 2024 | $94,660 |
| Brian Edward Miller EVP and Chief Digital Officer | Sale 16 May 2024 | $1,021,200 |
| Mark Brosius SVP, Chief Mfg, and Supply Cha | Sale 13 May 2024 | $202,514 |
| Robert De Santis EVP, Chief Strategy, and Corp Op | Option 10 May 2024 | $80,034 |
| Mark J Rubash Director | Option 3 May 2024 | $505,727 |
Powered by
Robintrack.
| Insider | Age | Since | Compensation |
|---|---|---|---|
| Dr. Gary S. Guthart (55) Pres, CEO, and Director | 55 | $822,975 | |
| David J. Rosa (53) Exec. VP, Chief Strategy, and Growth Officer | 53 | $591,468 | |
| Marshall L. Mohr (65) Exec. VP of Global Bus. Services | 65 | $567,750 | |
| Dr. Myriam J. Curet McAdams F.A.C.S., M.D. (64) Exec. VP and Chief Medical Officer | 64 | $566,375 | |
| Robert DeSantis (55) Exec. VP and Chief Product Officer | 55 | $532,552 | |
| Philip Kim | |||
| Fredrik Widman | |||
| Craig Child | |||
| Julian Nikolchev (66) Sr. VP of Corp. Devel. and Strategy | 66 | ||
| Kara Andersen Reiter (57) Sr. VP, Gen. Counsel, and Chief Compliance Officer | 57 | ||
| Calvin Darling | |||
| Jamie E. Samath (50) Chief Financial Officer | 50 |
Intuitive Surgical, Inc. is an American corporation that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System. The company is part of the NASDAQ-100 and S&P 500.
- Health Care > Health Care Supplies
- Intuitive Surgical Inc, 1020 Kifer Road, Sunnyvale 94086-5304, United States
- 408 523 2100
- Investor relations
Quarterly EPS estimates
Profit margin
Debt to assets
Cash flow
Balance sheet
XSLX
| (in millions USD) | 31 Mar 2024 | 31 Dec 2023 | |||
|---|---|---|---|---|---|
| Current assets | |||||
| Cash | $2,839.5 | $2,750.1 | |||
| Short term investments | $1,960.6 | $2,473.1 | |||
| Net receivables | $1,127.9 | $1,130.2 | |||
| Inventory | $1,299.3 | $1,220.6 | |||
| Total current assets | $7,632.7 | $7,888 | |||
| Long term investments | $2,522.6 | $2,120 | |||
| Property, plant & equipment | $3,799.6 | $3,537.6 | |||
| Goodwill & intangible assets | $955.3 | $985.4 | |||
| Total noncurrent assets | $8,195.3 | $7,553.5 | |||
| Total investments | $4,483.2 | $4,593.1 | |||
| Total assets | $15,828 | $15,441.5 | |||
| Current liabilities | |||||
| Accounts payable | $194.4 | $188.7 | |||
| Deferred revenue | $437.5 | $446.1 | |||
| Short long term debt | |||||
| Total current liabilities | $1,375.1 | $1,658.7 | |||
| Long term debt | |||||
| Total noncurrent liabilities | $406.5 | $385.5 | |||
| Total debt | |||||
| Total liabilities | $1,781.6 | $2,044.2 | |||
| Stockholders' equity | |||||
| Retained earnings | $5,067.9 | $4,743 | |||
| Other stockholder equity | -$8.7 | -$12.2 | |||
| Total stockholder equity | $13,962.6 | $13,307.6 | |||
| (in millions USD) | 2023 | 2022 | ||
|---|---|---|---|---|
| Current assets | ||||
| Cash | $2,750.1 | $1,581.2 | ||
| Short term investments | $2,473.1 | $2,536.7 | ||
| Net receivables | $1,130.2 | $942.1 | ||
| Inventory | $1,220.6 | $893.2 | ||
| Total current assets | $7,888 | $6,253 | ||
| Long term investments | $2,120 | $2,623.6 | ||
| Property, plant & equipment | $3,537.6 | $2,374.2 | ||
| Goodwill & intangible assets | $985.4 | $1,058.6 | ||
| Total noncurrent assets | $7,553.5 | $6,721 | ||
| Total investments | $4,593.1 | $5,160.3 | ||
| Total assets | $15,441.5 | $12,974 | ||
| Current liabilities | ||||
| Accounts payable | $188.7 | $147 | ||
| Deferred revenue | $446.1 | $397.3 | ||
| Short long term debt | ||||
| Total current liabilities | $1,658.7 | $1,422.1 | ||
| Long term debt | ||||
| Total noncurrent liabilities | $385.5 | $439.3 | ||
| Total debt | ||||
| Total liabilities | $2,044.2 | $1,861.4 | ||
| Stockholders' equity | ||||
| Retained earnings | $4,743 | $3,500.1 | ||
| Other stockholder equity | -$12.2 | -$162.5 | ||
| Total stockholder equity | $13,307.6 | $11,041.9 | ||
Income statement
| (in millions USD) | 31 Mar 2024 | 31 Dec 2023 | |||
|---|---|---|---|---|---|
| Revenue | |||||
| Total revenue | $1,890.6 | $1,928.3 | |||
| Cost of revenue | $645.2 | $650.9 | |||
| Gross profit | $1,245.4 | $1,277.4 | |||
| Operating activities | |||||
| Research & development | $284.5 | $260.1 | |||
| Selling, general & administrative | $491.5 | $567.1 | |||
| Total operating expenses | $776 | $827.2 | |||
| Operating income | $469.4 | $450.2 | |||
| Income from continuing operations | |||||
| EBIT | $536 | $511.4 | |||
| Income tax expense | -$8.9 | -$94.8 | |||
| Interest expense | |||||
| Net income | |||||
| Net income | $544.9 | $606.2 | |||
| Income (for common shares) | $544.9 | $606.2 | |||
| (in millions USD) | 2023 | 2022 | ||
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $7,124.1 | $6,222.2 | ||
| Cost of revenue | $2,394.6 | $2,026.2 | ||
| Gross profit | $4,729.5 | $4,196 | ||
| Operating activities | ||||
| Research & development | $998.8 | $879 | ||
| Selling, general & administrative | $1,963.9 | $1,739.9 | ||
| Total operating expenses | $2,962.7 | $2,618.9 | ||
| Operating income | $1,766.8 | $1,577.1 | ||
| Income from continuing operations | ||||
| EBIT | $1,939.6 | $1,584.7 | ||
| Income tax expense | $141.6 | $262.4 | ||
| Interest expense | ||||
| Net income | ||||
| Net income | $1,798 | $1,322.3 | ||
| Income (for common shares) | $1,798 | $1,322.3 | ||
Cash flows
| (in millions USD) | 31 Mar 2024 | 31 Dec 2023 | |||
|---|---|---|---|---|---|
| Net income | $544.9 | $606.2 | |||
| Operating activities | |||||
| Depreciation | $117.8 | $133.6 | |||
| Business acquisitions & disposals | -$1.8 | ||||
| Stock-based compensation | $153.3 | $150.4 | |||
| Total cash flows from operations | $265.4 | $228.3 | |||
| Investing activities | |||||
| Capital expenditures | -$241.9 | -$435.5 | |||
| Investments | $113.4 | -$606.9 | |||
| Total cash flows from investing | -$128.5 | -$1,044.2 | |||
| Financing activities | |||||
| Dividends paid | |||||
| Sale and purchase of stock | $180.4 | -$22.2 | |||
| Net borrowings | |||||
| Total cash flows from financing | -$46.7 | -$31.5 | |||
| Effect of exchange rate | $6.8 | -$5.4 | |||
| Change in cash and equivalents | $97 | -$852.8 | |||
| (in millions USD) | 2023 | 2022 | ||
|---|---|---|---|---|
| Net income | $1,798 | $1,322.3 | ||
| Operating activities | ||||
| Depreciation | $454.8 | $392.4 | ||
| Business acquisitions & disposals | -$8.9 | -$12.8 | ||
| Stock-based compensation | $592.8 | $513.2 | ||
| Total cash flows from operations | $1,813.8 | $1,490.8 | ||
| Investing activities | ||||
| Capital expenditures | -$1,064.2 | -$532.4 | ||
| Investments | $713 | $1,916 | ||
| Total cash flows from investing | -$360.1 | $1,370.8 | ||
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$120 | -$2,373.6 | ||
| Net borrowings | ||||
| Total cash flows from financing | -$287.6 | -$2,572.3 | ||
| Effect of exchange rate | $3.3 | $5.4 | ||
| Change in cash and equivalents | $1,169.4 | $294.7 | ||
Recent institutional transactions
| Quarter | Shareholder | Change |
Shares owned
Shares
|
Value (in thousands USD) |
|---|---|---|---|---|
| 2024 Q2 | Dnb Asset Management As |
-32.05%
|
83,633 | $37,204,140 |
| 2024 Q2 | Woodstock Corp |
-2.29%
|
92,647 | $41,214,018 |
| 2024 Q2 | Neville Rodie & Shaw Inc |
-12.39%
|
9,625 | $4,281 |
| 2024 Q2 | Douglas Lane & Associates |
+3.57%
|
39,388 | $17,521,751 |
| 2024 Q2 | Thurston, Springer, Miller, Herd & Titak, Inc |
Opened
|
972 | $432,342 |
| 2024 Q2 | Massmutual Trust Co Fsb/adv |
+13.76%
|
1,058 | $470,651 |
| 2024 Q2 | Versant Capital Management, Inc |
+28.34%
|
403 | $179,275 |
| 2024 Q2 | Moody National Bank Trust Division |
+1.55%
|
5,776 | $2,569,453 |
| 2024 Q2 | Stokes Family Office |
+4.25%
|
1,006 | $447,519 |
| 2024 Q2 | Hudson Valley Investment Advisors Inc adv |
-0.04%
|
71,620 | $23,552,953 |
Institutional shareholders
| Shareholder | Stake |
Shares owned
Shares
|
Value (in thousands USD) |
|---|---|---|---|
| Blackrock | 8.55% | 30,321,651 | |
| Vanguard Group Inc | 8.42% | 29,868,227 | |
| Price T Rowe Associates Inc md/ | 4.66% | 16,530,249 | |
| State Street Corp | 4.27% | 15,132,415 | |
| Fmr | 2.56% | 9,064,367 | |
| Capital World Investors | 2.05% | 7,284,269 | |
| Geode Capital Management | 1.96% | 6,938,605 | |
| Alliancebernstein L.P. | 1.91% | 6,766,225 | |
| Jpmorgan Chase & Co | 1.90% | 6,732,307 | |
| Bank Of New York Mellon Corp | 1.80% | 6,384,837 |
Sign up